David Ferrera Presents on the Regulatory Approval Process at ACI’s Drug and Medical Device Litigation ConferencePrint PDF
David Ferrera, a partner in Nutter’s Litigation Department and chair of the firm’s Product Liability practice group, will discuss the regulatory approval process at ACI’s Drug and Medical Device Litigation Conference. David will be a panelist on the Drug and Medical Device Litigator Think-Tank: “What I Wish Was Done Differently During the Regulatory Approval Process” session. The speakers will share challenges they have faced in litigation and reflect on what they wished was done during the FDA pre-approval, approval, or post-approval periods to prevent or mitigate issues that developed down the road. David will talk through scenarios where a more favorable outcome could have been achieved in litigation had the regulatory counsel done something differently with regard to the drug or device review and approval process; product labeling; clinical trials; and handling of post-approval challenges related to recalls and withdrawals.
ACI’s Drug and Medical Device Litigation conference has convened the greatest minds and leaders in the pharmaceutical and medical device industry for the last two decades. Designed for high-level strategy sharing and bringing together hundreds of industry leaders each year from in-house, private practice, and government, this is the only forum at which to gain essential winning life sciences product liability litigation strategies and anticipate what is next on the horizon.
Tuesday, December 6, 2022
NY Marriott Marquis
New York, NY 10036